|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.3 TWD | -0.55% |
|
+4.39% | +12.17% |
| 08/05 | CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 07/03 | CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index | CI |
CH Biotech R&D Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 1,434.12 million compared to TWD 1,018.51 million a year ago. Net income was TWD 465.42 million compared to TWD 291.5 million a year ago.
Basic earnings per share from continuing operations was TWD 4.79 compared to TWD 3 a year ago. Diluted earnings per share from continuing operations was TWD 4.72 compared to TWD 2.97 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.17% | 288M | |
| +17.80% | 39.34B | |
| -.--% | 11.28B | |
| +1.48% | 7.99B | |
| +1.79% | 6.51B | |
| -2.15% | 6.18B | |
| +36.99% | 5.43B | |
| -13.59% | 5.37B | |
| -13.00% | 4.61B | |
| +4.12% | 3.89B |
CH BIOTECH R&D CO., LTD. 
